...BRCA1 germ-line mutation carriers usually involves somatic inactivation of the remaining BRCA1 allele. This feature lead...
...BRCA1 or BRCA2 mutations. Currently, clinical trials with several PARP inhibitors are being conducted to assess the toxi...
...BRCA1 disruption; the latter may promote immunity through altered cytokine signaling, oxidative stress responses, or ant...
...BRCA1/2 carrier status before primary surgery. Considering the potential impact of knowing one's status on uptake and ti...
...BRCA1/2 mutation carriers with clinical breast exam, mammography and MRI has reported sensitivity of 100 %, but BRCA1/2 ...
...BRCA1 or BRCA2 gene and thereby normalize protein levels, contribute to stem cell homeostasis, and/or affect hormone lev...
...BRCA1, E2F1, FHIT, RUNX3, STK11, BCL2, CTNNB1).,The median overall survival was 142 (≤45 years) and 34 months (>45 years...
Stable retention of BRCA1/BARD1 complexes at sites of DNA damage is required for the proper response to DNA double-stran...
...BRCA1, BRCA2 and MSH2 that are predicted to disrupt splicing, prematurely truncate the protein, or remove the start codo...
...BRCA1 and BRCA2 mutations and polymorphisms. Genomic DNA was amplified using the Ion AmpliSeq BRCA1 and BRCA2 panel. The...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269